Ergotamine Tartrate
1 NDC across 1 manufacturer|0 Generic,1 Brand
Ergotamine Tartrate is used to treat cluster headache, migraine disorders and postpartum hemorrhage, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved before 1982, and the first generic was approved Jul 29, 1982. In 2024, Medicare Part D spent $207K on Ergotamine Tartrate across 138 claims for 61 beneficiaries.
Ergotamine Tartrate is available as 1 NDC from 1 manufacturer (0 generic, 1 brand), with NADAC prices from $43.16 to $43.16 per EA. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
1
0G / 1B
Manufacturers
1
competing in market
Price Spread
$43.16 – $43.16
per EA
7d Activity
avg +0.0% WoW · of 1 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Manufacturer Breakdown
1 manufacturer producing ERGOTAMINE TARTRATE
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
ERGOMAR 2 MG TABLET SUBLINGUAL | $43.1572 per EA | — |
Frequently Asked Questions
What is Ergotamine Tartrate used to treat?
Ergotamine Tartrate is used to treat cluster headache, migraine disorders and postpartum hemorrhage, per the National Library of Medicine's MED-RT classification.
When did Ergotamine Tartrate become available as a generic?
FDA approved the first generic Ergotamine Tartrate (ANDA) on Jul 29, 1982.
How much does Medicare spend on Ergotamine Tartrate?
In 2024, Medicare Part D spent $207K on Ergotamine Tartrate across 138 claims for 61 beneficiaries.
How many Ergotamine Tartrate products are on the market?
The Ergotamine Tartrate drug market contains 1 NDC from 1 manufacturer — 0 generic and 1 brand product.
What is the price range for Ergotamine Tartrate?
NADAC reference prices for Ergotamine Tartrate range from $43.1572 to $43.1572 per EA.
Which manufacturers make Ergotamine Tartrate?
1 manufacturer lists Ergotamine Tartrate in NADAC. Ranked by number of NDCs, the largest are Pangea Pharmaceuticals LLC (1).